文献速递细菌感染、耐药与抗菌药物医院感染防控

亚太地区住院抗菌药物管理系统评价与荟萃分析

Antimicrobial Stewardship in Inpatient Settings in the Asia Pacific Region: A Systematic Review and Meta-analysis.
PubMed 文献 · Clin Infect Dis · 2017-01-01

结论认为此类项目安全有效,但评估方法差异大,需标准化监测研究。

要点

  • 亚太住院抗菌药物管理可能降低抗菌药物消耗并改善部分结局。
  • 前后对照试验死亡率无显著变化,两组比较研究死亡率显著降低。
  • 总体和碳青霉烯类消耗分别下降约9.74%和10.56%。

核心结论

  • 亚太地区住院抗菌药物管理项目看似安全有效,可减少抗菌药物消耗并改善结局。
  • 因评估方法差异显著,需高质量标准化监测研究进一步推广。

研究设计与样本

  • 系统评价与荟萃分析,检索2005年1月至2016年3月亚太地区住院设置研究。

主要发现

  • 碳青霉烯类消耗变化合并效应量为-10.56%(95%CI -19.99%至-3.03%)。
  • 观察到多药耐药菌发生率和抗菌药物费用下降趋势,干预期/组费用降幅范围9.7%-58.1%。

临床怎么用

  • 在亚太住院环境中可考虑实施抗菌药物管理项目以减少抗菌药物消耗。
  • 实施时应关注死亡率等临床结局,并采用标准化指标监测消耗和结局。

局限性

  • 纳入研究在评估抗菌药物管理效果的方法上存在显著差异。
  • 缺乏标准化的抗菌药物消耗监测方法和统一的结局测量指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An antimicrobial stewardship program (ASP) is one of the core elements needed to optimize antimicrobial use. Although collaboration at the national level to address the importance of ASPs and antimicrobial resistance has occurred in the Asia Pacific region, hospital-level ASP implementation in this region has not been comprehensively evaluated. METHODS: We conducted a systematic review and meta-analysis to assess the efficacy of ASPs in inpatient settings in the Asia Pacific region from January 2005 through March 2016. The impact of ASPs on various outcomes, including patient clinical outcomes, antimicrobial prescription outcomes, microbiological outcomes, and expenditure were assessed. RESULTS: Forty-six studies were included for a systematic review and meta-analysis. The pooled risk ratio for mortality from ASP before-after trials and 2-group comparative studies were 1.03 (95% confidence interval [CI], .88-1.19) and 0.69 (95% CI, .56-.86), respectively. The pooled effect size for change in overall antimicrobial and carbapenem consumption (% difference) was -9.74% (95% CI, -18.93% to -.99%) and -10.56% (95% CI, -19.99% to -3.03%), respectively. Trends toward decreases in the incidence of multidrug-resistant organisms and antimicrobial expenditure (range, 9.7%-58.1% reduction in cost in the intervention period/arm) were also observed. CONCLUSIONS: ASPs in inpatient settings in the Asia Pacific region appear to be safe and effective to reduce antimicrobial consumption and improve outcomes. However, given the significant variations in assessing the efficacy of ASPs, high-quality studies using standardized surveillance methodology for antimicrobial consumption and similar metrics for outcome measurement are needed to further promote antimicrobial stewardship in this region.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Honda H, Ohmagari N, Tokuda Y, et al. Antimicrobial Stewardship in Inpatient Settings in the Asia Pacific Region: A Systematic Review and Meta-analysis. Clin Infect Dis. 2017. PMID: 28475777. doi:10.1093/cid/cix017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。